Jove
Visualize
Contact Us

Related Concept Videos

Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Hiatal Hernia01:25

Hiatal Hernia

A hiatal hernia is the abnormal protrusion of the stomach or other abdominal organs through the esophageal hiatus of the diaphragm into the thoracic cavity.Normally, the gastroesophageal junction (GEJ) lies below the diaphragm and is supported by the phrenoesophageal membrane, the diaphragmatic crura, and connective tissues. Weakening of these structures—due to aging, congenital defects like a short esophagus, or increased intra-abdominal pressure from coughing, obesity, pregnancy, or heavy...
Pyloric Obstruction01:11

Pyloric Obstruction

Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine manifestations of chronic HCV infection.

Minerva endocrinologica·2015
Same author

Benefit of supplements in functional dyspepsia after treatment of Helicobacter pylori.

Minerva gastroenterologica e dietologica·2014
Same author

Inflammatory bowel diseases and primary sclerosing cholangitis: hepatic and pancreatic side effects due to azathioprine.

European review for medical and pharmacological sciences·2013
Same author

Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.

Panminerva medica·2011
Same author

Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment.

Minerva medica·2011
Same author

The diagnosis of gastroesophageal reflux disease.

Minerva gastroenterologica e dietologica·2007
Same journal

Hepatic steatosis integrated approach: nutritional guidelines and joined nutraceutical administration.

Minerva gastroenterologica e dietologica·2021
Same journal

Diagnostic accuracy of computerized tomography (CT) angiography in detecting non-variceal gastrointestinal bleeding (NVGIB): a sistematic review.

Minerva gastroenterologica e dietologica·2020
Same journal

Helicobacter pylori and non-alcoholic fatty liver disease.

Minerva gastroenterologica e dietologica·2020
Same journal

Hypertriglyceridemic pancreatitis.

Minerva gastroenterologica e dietologica·2020
Same journal

Effectiveness of percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis.

Minerva gastroenterologica e dietologica·2020
Same journal

Noninvasive diagnosis of fibrosis in non-alcoholic fatty liver disease: diagnostic accuracy of different scores.

Minerva gastroenterologica e dietologica·2020
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Achalasia.

L Dughera1, P Cassolino, F Cisarò

  • 1Motility and Endoscopy Unit, Department of Internal Medicine, San Giovanni Battista Hospital, Turin, Italy. luca.dughera@libero.it

Minerva Gastroenterologica E Dietologica
|July 11, 2008
PubMed
Summary
This summary is machine-generated.

Achalasia is a rare esophageal motility disorder causing difficulty swallowing and food retention. Current treatments aim to reduce lower esophageal sphincter pressure, offering palliative relief for this condition.

More Related Videos

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Related Experiment Videos

Last Updated: Jul 3, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
11:19

Robotic Myotomy and Partial Fundoplication for Achalasia

Published on: August 11, 2023

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia
09:46

Robotic Heller Myotomy for Advancements in Surgical Management of Achalasia

Published on: February 16, 2024

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
06:42

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia

Published on: March 3, 2023

Area of Science:

  • Gastroenterology
  • Esophageal Motility Disorders
  • Clinical Diagnosis and Management

Background:

  • Achalasia is a rare esophageal motor disorder characterized by absent peristalsis and impaired lower esophageal sphincter relaxation.
  • This leads to esophageal food stasis, causing symptoms like dysphagia, regurgitation, chest pain, and weight loss.
  • The exact etiology remains unknown, with limited evidence for genetic inheritance, though viral infections and autoimmune factors are being investigated.

Purpose of the Study:

  • To provide a comprehensive overview of achalasia, covering its pathophysiology, diagnostic approaches, and current therapeutic strategies.
  • To highlight the diagnostic gold standard and the roles of various imaging and endoscopic modalities.
  • To discuss the palliative nature of existing treatments for achalasia.

Main Methods:

  • Review of existing literature on achalasia pathophysiology, diagnosis, and treatment.
  • Emphasis on esophageal manometry as the gold standard for diagnosis.
  • Discussion of radiological studies and endoscopy in diagnosis and surveillance.
  • Analysis of current medical and surgical interventions.

Main Results:

  • Esophageal manometry is the definitive diagnostic tool, though its role in post-treatment surveillance is debated.
  • Radiology aids initial diagnosis and recurrence detection; endoscopy is crucial for excluding secondary causes.
  • Current treatments, including pneumatic dilation, myotomy, and medications, focus on reducing lower esophageal sphincter pressure.

Conclusions:

  • Achalasia is a complex esophageal motility disorder with unknown etiology.
  • Accurate diagnosis relies on esophageal manometry, supported by imaging and endoscopy.
  • Treatment is palliative, aiming to improve esophageal emptying and alleviate symptoms.